Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00156702 · ClinicalTrials.gov registry record · Phase 1

Researching the Youth Smoking Experience

A Phase 1 study, sponsored by Virginia Commonwealth University.

Completed
Registry status
Phase 1
Development phase
40
Enrollment target

NCT00156702: Completed Phase 1 study, sponsored by Virginia Commonwealth University.

NCT00156702 is a Phase 1 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 40 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00156702, a Phase 1 study, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
Phase 1
Development phase
40 participants
Enrollment target

Study Summary

The primary hypothesis of this pilot study is that dependence can be prevented in adolescents who smoke, but who are not yet dependent. With this study, we seek to develop and test the feasibility and provide controlled comparisons of two brief smoking dependence-prevention interventions: motivational interviewing with feedback versus a video control. Forty adolescents between the ages of 12 and 18 will be enrolled. The evaluation and dependence-prevention phases will occur during a single 3- to 4-hour session, and the 30-45 minute follow-up sessions will take place approximately one month, three months, six months, and one year after the completion of the evaluation and dependence prevention phases.

Interventions

  • BEHAVIORAL Feedback and Motivational Interviewing
  • BEHAVIORAL Smoking Prevention Video

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2001-01
Est. Completion 2006-10
Phase Phase 1
Virginia Commonwealth University

558 total trials

What the finished NCT00156702 record still lists

NCT00156702 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% lower).

The record links to 0 conditions, and to 2 interventions - of which Feedback and Motivational Interviewing is the first listed.

NCT00156702 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00156702 about?

NCT00156702 is a clinical study titled "Researching the Youth Smoking Experience". The primary hypothesis of this pilot study is that dependence can be prevented in adolescents who smoke, but who are not yet dependent. With this study, we seek to develop and test the feasibility and provide controlled comparisons of two brief smoking dependence-prevention interventions: motivation...

What is the current status of trial NCT00156702?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2001-01. Estimated completion is 2006-10.

What interventions are being tested in trial NCT00156702?

The interventions under investigation include: Feedback and Motivational Interviewing (BEHAVIORAL), Smoking Prevention Video (BEHAVIORAL).

Who is sponsoring clinical trial NCT00156702?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00156702's enrollment target sits among peer trials

40 1130th of 2000 higher than 810 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00156702, the US trial registry maintained by the National Library of Medicine. NCT00156702 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.